During the past decade, Multiscan s.r.o. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Multiscan s.r.o." #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Acrotech Biopharma Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Multiscan s.r.o." #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Multiscan s.r.o." are "Breast Cancer" (8 trials), "Bladder Cancer" (1 trials), "Breast Neoplasm" (1 trials), "Breast Neoplasms" (1 trials) and "Breast Tumors" (1 trials). Many other conditions were trialed in "Multiscan s.r.o." in a lesser frequency.

Most popular intervention types in "Multiscan s.r.o." are "Drug" (19 trials), "Other" (2 trials), "Dietary Supplement" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (6 trials), "Docetaxel" (5 trials), "Atezolizumab" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Multiscan s.r.o." are 12 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Multiscan s.r.o.". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Multiscan s.r.o., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Multiscan s.r.o., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".